Eledon Pharmaceuticals
Stock Forecast, Prediction & Price Target
Eledon Pharmaceuticals Financial Estimates
Eledon Pharmaceuticals Revenue Estimates
Eledon Pharmaceuticals EBITDA Estimates
Eledon Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $33.33M Low: $33.33M High: $33.33M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $17.4M Low: $17.4M High: $17.4M avg. 0% |
Net Income
% change YoY
| $-34.50M N/A | $-87.50M -153.59% | $-40.32M 53.91% | Avg: $-33.55M Low: $-40.62M High: $11.32M avg. 16.78% | Avg: $-70.7M Low: $-17.97M High: $-17.97M avg. -110.69% | Avg: $-21.41M Low: $-21.41M High: $-21.41M avg. 69.70% | Avg: $-20.18M Low: $-20.18M High: $-20.18M avg. 5.74% |
EBITDA
% change YoY
| $-36.86M N/A | $8.86M 124.05% | $0 -100% | Avg: $19.99M Low: $19.99M High: $19.99M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $10.44M Low: $10.44M High: $10.44M avg. 0% |
EPS
% change YoY
| -$2.33 N/A | -$6.13 -163.09% | -$0 99.97% | Avg: -$0.62 Low: -$1.65 High: $0.46 avg. -38858.12% | Avg: -$0.73 Low: -$0.73 High: -$0.73 avg. -17.11% | Avg: -$0.87 Low: -$0.87 High: -$0.87 avg. -19.17% | Avg: -$0.82 Low: -$0.82 High: -$0.82 avg. 5.74% |
Operating Expenses
% change YoY
| $36.86M N/A | $39.78M 7.90% | $43M 8.09% | Avg: $585.11M Low: $585.11M High: $585.11M avg. 1260.72% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $305.42M Low: $305.42M High: $305.42M avg. 0% |
FAQ
What is Eledon Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -4.61% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -40.62M, average is -33.55M and high is 11.32M.
What is Eledon Pharmaceuticals stock revenue growth forecast?
We have gathered data from 2 analysts. Their low revenue estimate is $33.33M, average is $33.33M and high is $33.33M.
What is Eledon Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -9722.16% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.65, average is -$0.62 and high is $0.46.